Priority review is a designation granted by the U.S. Food and Drug Administration (FDA) to certain drug applications that, if approved, would provide significant improvements in the treatment, diagnosis, or prevention of serious conditions. Under this designation, the FDA aims to take action on an application within six months, compared to ten months under standard review.
Priority review is a designation granted by the U.S. Food and Drug Administration (FDA) to certain drug applications that, if approved, would provide significant improvements in the treatment, diagnosis, or prevention of serious conditions. Under this designation, the FDA aims to take action on an application within six months, compared to ten months under standard review.
Source: Wikipedia "Priority review" · CC BY-SA 4.0
Share this article: X · Bluesky